1. Home
  2. FGEN vs SWIN Comparison

FGEN vs SWIN Comparison

Compare FGEN & SWIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FGEN
  • SWIN
  • Stock Information
  • Founded
  • FGEN 1993
  • SWIN 2017
  • Country
  • FGEN United States
  • SWIN Hong Kong
  • Employees
  • FGEN N/A
  • SWIN N/A
  • Industry
  • FGEN Biotechnology: Pharmaceutical Preparations
  • SWIN
  • Sector
  • FGEN Health Care
  • SWIN
  • Exchange
  • FGEN Nasdaq
  • SWIN Nasdaq
  • Market Cap
  • FGEN 33.5M
  • SWIN 214.1M
  • IPO Year
  • FGEN 2014
  • SWIN 2023
  • Fundamental
  • Price
  • FGEN $6.92
  • SWIN $4.09
  • Analyst Decision
  • FGEN Strong Buy
  • SWIN
  • Analyst Count
  • FGEN 1
  • SWIN 0
  • Target Price
  • FGEN $250.00
  • SWIN N/A
  • AVG Volume (30 Days)
  • FGEN 40.3K
  • SWIN 207.8K
  • Earning Date
  • FGEN 08-12-2025
  • SWIN 08-21-2025
  • Dividend Yield
  • FGEN N/A
  • SWIN N/A
  • EPS Growth
  • FGEN N/A
  • SWIN N/A
  • EPS
  • FGEN N/A
  • SWIN N/A
  • Revenue
  • FGEN $6,996,000.00
  • SWIN $3,316,000.00
  • Revenue This Year
  • FGEN N/A
  • SWIN $29.79
  • Revenue Next Year
  • FGEN N/A
  • SWIN $54.60
  • P/E Ratio
  • FGEN N/A
  • SWIN N/A
  • Revenue Growth
  • FGEN N/A
  • SWIN N/A
  • 52 Week Low
  • FGEN $4.50
  • SWIN $1.16
  • 52 Week High
  • FGEN $21.94
  • SWIN $4.40
  • Technical
  • Relative Strength Index (RSI)
  • FGEN 48.67
  • SWIN 64.67
  • Support Level
  • FGEN $7.04
  • SWIN $3.70
  • Resistance Level
  • FGEN $7.56
  • SWIN $3.99
  • Average True Range (ATR)
  • FGEN 0.47
  • SWIN 0.32
  • MACD
  • FGEN -0.03
  • SWIN -0.02
  • Stochastic Oscillator
  • FGEN 7.71
  • SWIN 86.73

About FGEN FibroGen Inc

FibroGen Inc is a biotechnology company focused on discovering, developing, and commercializing novel therapeutics to treat serious cancer biology and anemia. The company operates in one reportable segment: the development and commercialization of novel therapeutics to treat serious unmet medical needs. The company generates the vast majority of its revenue in Europe, followed by Japan. Virtually all of FibroGen's revenue to date has been generated from its collaboration agreements. FibroGen seeks partners with research, development, and marketing capabilities and other resources that strengthen the company's ability to advance product candidates. Geographically, it operates in United States, Japan, Europe and Others.

About SWIN Solowin Holdings

Solowin Holdings Ltd is an investor-focused, versatile securities brokerage company in Hong Kong. It offers a wide spectrum of products and services through its secure one-stop electronic platform. It is engaged in providing securities-related services, investment advisory services, and asset management services to customers. The operations were organized into four reportable segments: Corporate Finance Services, Wealth Management Services, Asset Management Services and Virtual Assets. It derives maximum revenue from Wealth Management Services.

Share on Social Networks: